pharmacokinetic interaction
Showing 1 - 25 of 9,806
Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)
Active, not recruiting
- Drug Interaction
- Nitazoxanide
- "Nitazoxanide" and "atazanavir/ritonavir" separately
-
Ile-Ife, Osun, NigeriaObafemi Awolowo University
Jan 8, 2023
Hypertension, Diabetes, Type 2 Trial in Seoul (THP-00101 (Dapagliflozin) 10mg, THP-00102 (Telmisartan) 80mg)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- THP-00101 (Dapagliflozin) 10mg
- THP-00102 (Telmisartan) 80mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Sep 25, 2023
The Effect of S-ketamine on Pharmacokinetics of Morphine, Hydromorphone, and Buprenorphine Trial (S-ketamine)
Not yet recruiting
- The Effect of S-ketamine on Pharmacokinetics of Morphine, Hydromorphone, and Buprenorphine
- (no location specified)
Oct 4, 2022
Hypertension, Diabetes, Type 2 Trial in Incheon (BR1019-1, BR1019-2, BR1019-1 + BR1019-2)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- BR1019-1
- +2 more
-
Incheon, Korea, Republic ofInha University Hospital
May 16, 2023
Herbal Interaction Trial in Spokane (Kratom, Oxycodone)
Not yet recruiting
- Herbal Interaction
- Kratom
- Oxycodone
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Apr 26, 2023
Healthy Trial in Mexico City (A1: Ibuprofen/Acetaminophen Fixed dose combination oral suspension (Laboratorios Silanes S.A. de
Completed
- Healthy
- A1: Ibuprofen/Acetaminophen Fixed dose combination oral suspension (Laboratorios Silanes S.A. de C.V.)
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Jun 22, 2022
Healthy Trial in Mexico City (A1: Ibuprofen/Acetaminophen Fixed dose combination (Laboratorios Silanes S.A. de C.V.), A2:
Completed
- Healthy
- A1: Ibuprofen/Acetaminophen Fixed dose combination (Laboratorios Silanes S.A. de C.V.)
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Jun 22, 2022
COPD Trial in Antwerpen (Glycopyrrolate + Formoterol, Glycopyrrolate, Formoterol)
Completed
- COPD
- Glycopyrrolate + Formoterol
- +3 more
-
Antwerpen, Lange Beeldekensstraat 267, BelgiumClinical Pharmacology Unit - SGS Life Science Services
Oct 28, 2021
Determining Clinical Relevance of inTeraction Between AprepitaNt
Completed
- Testicular Cancer
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, NetherlandsRadboud UMC
Sep 9, 2022
Interaction, Adverse Herb-Drug, Diabetes, Type 2 Trial in Spokane (Midazolam Hcl 1Mg/Ml Inj, Goldenseal (Hydrastis canadensis))
Active, not recruiting
- Interaction, Adverse Herb-Drug
- Diabetes Mellitus, Type 2
- Midazolam Hcl 1Mg/Ml Inj
- Goldenseal (Hydrastis canadensis)
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Nov 18, 2022
Drug-drug Interaction Trial in Queensland (DWC202005, alone, DWP14012 + DWC202005, DWP14012 + DWC202005, after multiple doses of
Completed
- Drug-drug Interaction
- DWC202005, alone
- +2 more
-
Queensland, AustraliaNucleus Network (QPharm)
Aug 13, 2021
Healthy Participants Trial in Brussels (PF-07258669, Placebo, Midazolam)
Recruiting
- Healthy Participants
- PF-07258669
- +2 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Nov 28, 2022
Healthy Adult Volunteers Trial in Seoul (Olmesartan, Dapagliflozin)
Completed
- Healthy Adult Volunteers
-
Seoul, Gwanak-gu, Korea, Republic ofH Plus Yangji Hospital
Aug 31, 2021
Interaction, Endogenous Biomarkers Trial in Spokane (MetFORMIN Oral Solution, Cimetidine 400 MG, Furosemide Oral Liquid Product)
Recruiting
- Interaction
- Endogenous Biomarkers
- MetFORMIN Oral Solution
- +3 more
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Sep 8, 2022
Healthy Trial in Miami (Midazolam, SSP-004184SS)
Completed
- Healthy
-
Miami, FloridaClinical Pharmacology of Miami, Inc.
Jun 22, 2021
Health, Subjective Trial in Seoul (Drug: Treatment A, Drug: Treatment B, Drug: Treatment C)
Completed
- Health, Subjective
- Drug: Treatment A
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Dec 21, 2021
Healthy Participants Trial in Groningen (AB521, Placebo, Midazolam)
Recruiting
- Healthy Participants
- AB521
- +2 more
-
Groningen, NetherlandsInvestigational Site
Dec 6, 2022
Health, Subjective Trial in Seoul (CTL0801 (Azilsartan), CTL0802 (Rosuvastatin), CTL0801 (Azilsartan) + CTL0802 (Rosuvastatin))
Completed
- Health, Subjective
- CTL0801 (Azilsartan)
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Dec 21, 2021
Healthy Trial (Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg)
Not yet recruiting
- Healthy
- Tegoprazan 50mg
- +3 more
- (no location specified)
Feb 2, 2023
Healthy Trial in Mexico City (Rosuvastatin (20mg) /Ezetimibe (10mg) in fixed dose, Rosuvastatin 20mg, Ezetimibe 10mg)
Completed
- Healthy
- Rosuvastatin (20mg) /Ezetimibe (10mg) in fixed dose
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Aug 20, 2021
Hypertension Trial in Seoul (AD-2101, AD-2102, AD-2101 + AD-2102)
Completed
- Hypertension
- AD-2101
- +2 more
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Jul 20, 2021
Determining Clinical Relevance of Interaction Between
Recruiting
- Drug-drug Interaction
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, Netherlands
- +2 more
Oct 26, 2022